Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Christian Ring

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Experimental Dermatology|March 8, 2017
Haematoxylin and eosin staining identifies medium to large bacterial aggregates with a reliable specificity: A comparative analysis of follicular bacterial aggregates in axillary biopsies using peptide nucleic acid-fluorescence in situ hybridization and haematoxylin and eosin stainingHans Christian Ring, Peter Theut Riis, Lene Bay, et al.
Ugeskrift for Laeger|October 18, 2022
[Bullous skin diseases]Jeanette Kaae, Rikke Bech, Elisabeth Hjardem Taudorf, et al.
Medical Microbiology and Immunology|September 4, 2020
Bacterial aggregate size determines phagocytosis efficiency of polymorphonuclear leukocytesMaria Alhede, Melanie Lorenz, Blaine Gabriel Fritz, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 1, 2024
Effectiveness, safety and drug survival of oral roflumilast for hidradenitis suppurativaNikolaj Holgersen, Valdemar Wendelboe Nielsen, Hans Christian Ring, et al.
Health Science Reports|September 23, 2021
Liver enzyme levels are associated with markers of systemic inflammation, disease severity, and metabolic syndrome in patients with hidradenitis suppurativaValdemar Wendelboe Nielsen, Jesper Grønlund Holm, Astrid-Helene Ravn Jørgensen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 18, 2024
Evaluating oral roflumilast in patients with hidradenitis suppurativa previously exposed to biologic treatmentNikolaj Holgersen, Valdemar Wendelboe Nielsen, Hans Christian Ring, et al.
Archives of Dermatological Research|December 19, 2019
Factors affecting quality of life in patients with hidradenitis suppurativaAstrid-Helene Ravn Jørgensen, Jesper Grønlund Holm, Misbah Noshela Ghazanfar, et al.
Journal of the American Academy of Dermatology|September 17, 2025
Impact of psychiatric disease and treatment on biologic drug survival in patients with hidradenitis suppurativaNikolaj Holgersen, Valdemar Wendelboe Nielsen, Hans-Christian Ring, et al.
JAMA Dermatology|December 1, 2021
Drug Survival of Biologics in Patients With Hidradenitis SuppurativaHans Christian Ring, Julia-Tatjana Maul, Yiqiu Yao, et al.
Dermatology (Basel, Switzerland)|June 12, 2016
Leukocyte Profile in Peripheral Blood and Neutrophil-Lymphocyte Ratio in Hidradenitis Suppurativa: A Comparative Cross-Sectional Study of 462 CasesIben Marie Miller, Hans Christian Ring, Errol P Prens, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Experimental Dermatology|March 8, 2017
Haematoxylin and eosin staining identifies medium to large bacterial aggregates with a reliable specificity: A comparative analysis of follicular bacterial aggregates in axillary biopsies using peptide nucleic acid-fluorescence in situ hybridization and haematoxylin and eosin stainingHans Christian Ring, Peter Theut Riis, Lene Bay, et al.
Ugeskrift for Laeger|October 18, 2022
[Bullous skin diseases]Jeanette Kaae, Rikke Bech, Elisabeth Hjardem Taudorf, et al.
Medical Microbiology and Immunology|September 4, 2020
Bacterial aggregate size determines phagocytosis efficiency of polymorphonuclear leukocytesMaria Alhede, Melanie Lorenz, Blaine Gabriel Fritz, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|July 1, 2024
Effectiveness, safety and drug survival of oral roflumilast for hidradenitis suppurativaNikolaj Holgersen, Valdemar Wendelboe Nielsen, Hans Christian Ring, et al.
Health Science Reports|September 23, 2021
Liver enzyme levels are associated with markers of systemic inflammation, disease severity, and metabolic syndrome in patients with hidradenitis suppurativaValdemar Wendelboe Nielsen, Jesper Grønlund Holm, Astrid-Helene Ravn Jørgensen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 18, 2024
Evaluating oral roflumilast in patients with hidradenitis suppurativa previously exposed to biologic treatmentNikolaj Holgersen, Valdemar Wendelboe Nielsen, Hans Christian Ring, et al.
Archives of Dermatological Research|December 19, 2019
Factors affecting quality of life in patients with hidradenitis suppurativaAstrid-Helene Ravn Jørgensen, Jesper Grønlund Holm, Misbah Noshela Ghazanfar, et al.
Journal of the American Academy of Dermatology|September 17, 2025
Impact of psychiatric disease and treatment on biologic drug survival in patients with hidradenitis suppurativaNikolaj Holgersen, Valdemar Wendelboe Nielsen, Hans-Christian Ring, et al.
JAMA Dermatology|December 1, 2021
Drug Survival of Biologics in Patients With Hidradenitis SuppurativaHans Christian Ring, Julia-Tatjana Maul, Yiqiu Yao, et al.
Dermatology (Basel, Switzerland)|June 12, 2016
Leukocyte Profile in Peripheral Blood and Neutrophil-Lymphocyte Ratio in Hidradenitis Suppurativa: A Comparative Cross-Sectional Study of 462 CasesIben Marie Miller, Hans Christian Ring, Errol P Prens, et al.
Pageof 6